Timing and Resistance Exercise: Impact on Eating and Metabolism
Launched by NATIONAL TAIWAN NORMAL UNIVERSITY · Aug 8, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the timing of resistance exercise, whether done in the morning or evening, affects eating habits and metabolism. Researchers want to find out if working out at different times of the day can lead to better weight control and changes in appetite. The study will involve 18 healthy young men aged 20 to 30 who have maintained a stable weight for at least six months. Participants will go through different phases: exercising in the morning, exercising in the evening, and a control phase where they don’t exercise.
During the study, participants will be asked about their feelings of hunger, and researchers will measure certain hormones related to appetite, food preferences, and how much energy they burn. By comparing these results, the team hopes to learn more about how the timing of exercise can impact metabolism and eating behaviors. This information could help people choose the best time to work out based on their daily routines and support healthier lifestyles. It’s also important to note that individuals with certain health conditions, such as obesity or heart disease, will not be eligible to participate.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Age: 20-30
- • weight stable for at least 6 months
- Exclusion Criteria:
- • Obesity (BMI \> 30 kg/m² or body fat percentage \> 25%)
- • Hypertension (blood pressure over 140/90 mmHg)
- • Heart disease
- • Cancer
- • Liver or kidney diseases
- • Any other conditions that could potentially influence the study's outcomes
About National Taiwan Normal University
National Taiwan Normal University (NTNU) is a prestigious institution dedicated to advancing education and research across various disciplines, including health sciences. As a clinical trial sponsor, NTNU leverages its academic expertise and innovative methodologies to investigate and develop novel therapeutic interventions. The university fosters collaboration between researchers, healthcare professionals, and industry partners to ensure rigorous study design, ethical standards, and comprehensive data analysis. By prioritizing scientific excellence and community health, NTNU aims to contribute significantly to the advancement of medical knowledge and the improvement of patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Hung-wen Liu, Ph.D.
Principal Investigator
National Taiwan Normal University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported